Safety profile of Dupilumab during pregnancy: a data mining and disproportionality analysis of over 37,000 reports from the WHO individual case safety reporting database (VigiBase ™)
In conclusion, Dupilumab use appears safe during gestation. Further studies are needed, especially to better understand the mechanisms underlying the pharmacological actions and ADR of Dupilumab.PMID:34533820 | DOI:10.26355/eurrev_202109_26652
Source: Pharmacological Reviews - Category: Drugs & Pharmacology Authors: R Khamisy-Farah G Damiani J D Kong J-H Wu N L Bragazzi Source Type: research
More News: Databases & Libraries | Dermatitis | Dermatology | Drugs & Pharmacology | Eczema | Miscarriage | Perinatology & Neonatology | Pregnancy | Skin | Study